Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Mol Imaging Biol. 2022 Sep 7;25(2):401–412. doi: 10.1007/s11307-022-01770-w

Figure 2.

Figure 2.

Omniparticle contrast agent imaging capabilities. Phantoms showed imaged with A) Magnetic Particle Imaging (particle signal intensity (inset) overlaid with photo); B) Magnetic Resonance Imaging (1 – MNP core [30]; 2 – MNP core conjugated to Cy5.5; 3 – MNP core conjugated to Cy5.5 and thyroxine; 4 – completely oxidized nanoparticle core; 5 – water); C) Fluorescence imaging, D) Photoacoustic imaging, E) PET imaging and F) 3D computed tomography image afforded after T4 conjugation.